Skip to main content
Contact Us
Subscribe
E-Edition
52°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Entertainment
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aprea Therapeutics Inc
(NQ:
APRE
)
3.450
-0.100 (-2.82%)
Streaming Delayed Price
Updated: 11:34 AM EDT, Jun 6, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aprea Therapeutics Inc
< Previous
1
2
3
4
Next >
Aprea Therapeutics to Present at BIO International Convention
May 30, 2023
From
Aprea Therapeutics
Via
GlobeNewswire
Aprea Therapeutics Reports First Quarter 2023 Financial Results and Provides Update on Business Operations
May 15, 2023
From
Aprea Therapeutics
Via
GlobeNewswire
Aprea Therapeutics Appoints Gabriela Gruia, M.D. to Board of Directors
May 08, 2023
From
Aprea Therapeutics
Via
GlobeNewswire
Aprea Therapeutics Inc. (NASDAQ: APRE) Making Surprising Moves in Thursday Session
April 06, 2023
Via
Investor Brand Network
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 07, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
April 03, 2023
On Monday, 76 companies set new 52-week lows.
Via
Benzinga
Aprea Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Update on Business Operations
March 30, 2023
From
Aprea Therapeutics
Via
GlobeNewswire
Aprea Therapeutics Announces Presentation of Preclinical Data on Pipeline Programs at the AACR 2023 Annual Meeting
March 16, 2023
From
Aprea Therapeutics
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2023
March 10, 2023
Via
Benzinga
Aprea Therapeutics to Present at Oppenheimer’s 33rd Annual Healthcare Conference
March 07, 2023
From
Aprea Therapeutics
Via
GlobeNewswire
Aprea Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
March 01, 2023
From
Aprea Therapeutics
Via
GlobeNewswire
Aprea Therapeutics Announces Closing of $5.5 Million Underwritten Public Offering of Common Stock
February 27, 2023
From
Aprea Therapeutics
Via
GlobeNewswire
Why Aprea Therapeutics Shares Hit A New 52-Week Low Today
February 23, 2023
Aprea Therapeutics Inc (NASDAQ: APRE) shares are trading lower by 17.59% to $5.20 after the company announced pricing of a $5.5 million underwritten public offering of common stock. What Else?
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 23, 2023
Via
Benzinga
Aprea Therapeutics Announces Pricing of $5.5 Million Underwritten Public Offering of Common Stock
February 22, 2023
From
Aprea Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 22, 2023
Via
Benzinga
Aprea Therapeutics Announces Proposed Public Offering of Common Stock
February 22, 2023
From
Aprea Therapeutics
Via
GlobeNewswire
Aprea Therapeutics Announces Phase II SBIR Award from the National Cancer Institute (NCI)
February 15, 2023
From
Aprea Therapeutics
Via
GlobeNewswire
Aprea Therapeutics Announces One-for-Twenty Reverse Stock Split
February 13, 2023
From
Aprea Therapeutics
Via
GlobeNewswire
Aprea Therapeutics Appoints John Hamill as Chief Financial Officer
January 30, 2023
From
Aprea Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
January 19, 2023
Via
Benzinga
Aprea Therapeutics to Participate in 6th Annual DNA Damage and Response (DDR) Inhibitors Summit
January 19, 2023
From
Aprea Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 11, 2023
Via
Benzinga
Aprea Therapeutics Announces Dosing of First Patient in Phase 1/2a Clinical Trial of Oral ATR Inhibitor ATRN-119 for the Treatment of Advanced Solid Tumors
January 11, 2023
From
Aprea Therapeutics
Via
GlobeNewswire
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 05, 2023
Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 07, 2022
Via
Benzinga
Why Iovance Biotherapeutics Shares Are Trading Higher By Around 19%? Here Are 40 Stocks Moving In Monday's Mid-Day Session
December 05, 2022
Gainers Winc, Inc. (NYSE: WBEV) rose 88.5% to $0.3901 after dropping over 23% on Friday. Winc, last month, posted a Q3 loss of $0.33 per share.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 11, 2022
Gainers
Via
Benzinga
Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday
November 14, 2022
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday.
Via
Benzinga
Why Compass Shares Are Trading Higher By Over 56%? Here Are 63 Stocks Moving In Friday's Mid-Day Session
November 11, 2022
Gainers Snail, Inc. (NASDAQ: SNAL) shares jumped 74.9% to $3.9350 after the company announced a $5 million share repurchase program.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
